Oliveira Francisco A, Costa Charllynton L S, Chaves Mariana H, Almeida Fernanda R C, Cavalcante Italo J M, Lima Alana F, Lima Roberto C P, Silva Regilane M, Campos Adriana Rolim, Santos Flavia A, Rao Vietla S N
Departamento de Fisiologia e Farmacologia, Universidade Federal do Ceará, Rua Cel Nunes de Melo-1127, Caixa Postal-3157, 60430-270, Fortaleza, CE, Brazil.
Life Sci. 2005 Oct 21;77(23):2942-52. doi: 10.1016/j.lfs.2005.05.031. Epub 2005 Jun 16.
The triterpene mixture, alpha- and beta-amyrin, isolated from Protium heptaphyllum resin was evaluated on capsaicin-evoked nociception in mice. Orally administered alpha- and beta-amyrin (3 to 100 mg/kg) significantly suppressed the nociceptive behaviors--evoked by either subplantar (1.6 microg) or intracolonic (149 microg) application of capsaicin. The antinociception produced by alpha- and beta-amyrin against subplantar capsaicin-induced paw-licking behavior was neither potentiated nor attenuated by ruthenium red (1.5 mg/kg, s.c.), a non-specific antagonist of vanilloid receptor (TRPV1), but was greatly abolished in animals pretreated with naloxone (2 mg/kg, s.c.), suggesting an opioid mechanism. However, participation of alpha2-adrenoceptor involvement was unlikely since yohimbine (2 mg/kg, i.p.) pretreatment failed to block the antinociceptive effect of alpha- and beta-amyrin in the experimental model of visceral nociception evoked by intracolonic capsaicin. The triterpene mixture (3 to 30 mg/kg, p.o.) neither altered significantly the pentobarbital sleeping time, nor impaired the ambulation or motor coordination in open-field and rota-rod tests, respectively, indicating the absence of sedative or motor abnormality that could account for its antinociception. Nevertheless, alpha- and beta-amyrin could significantly block the capsaicin (10 mg/kg, s.c.)-induced hyperthermic response but not the initial hypothermia. These results suggest that the triterpene mixture, alpha- and beta-amyrin has an analgesia inducing effect, possibly involving vanilloid receptor (TRPV1) and an opioid mechanism.
从七叶普罗梯木树脂中分离得到的三萜混合物α-和β-香树脂醇,在小鼠辣椒素诱发的伤害感受实验中进行了评估。口服给予α-和β-香树脂醇(3至100毫克/千克)可显著抑制足底(1.6微克)或结肠内(149微克)注射辣椒素诱发的伤害行为。α-和β-香树脂醇对足底辣椒素诱导的舔足行为产生的抗伤害作用,既不会被香草酸受体(TRPV1)的非特异性拮抗剂钌红(1.5毫克/千克,皮下注射)增强,也不会被其减弱,但在用纳洛酮(2毫克/千克,皮下注射)预处理的动物中,这种作用会大大消除,提示存在阿片类机制。然而,α2-肾上腺素能受体不太可能参与其中,因为育亨宾(2毫克/千克,腹腔注射)预处理未能阻断α-和β-香树脂醇在结肠内辣椒素诱发的内脏伤害感受实验模型中的抗伤害作用。三萜混合物(3至30毫克/千克,口服)既不会显著改变戊巴比妥睡眠时间,也不会分别在旷场试验和转棒试验中损害行走或运动协调性,表明不存在可解释其抗伤害作用的镇静或运动异常。尽管如此,α-和β-香树脂醇可显著阻断辣椒素(10毫克/千克,皮下注射)诱导的体温升高反应,但不能阻断初始体温降低。这些结果表明,三萜混合物α-和β-香树脂醇具有镇痛诱导作用,可能涉及香草酸受体(TRPV1)和阿片类机制。